NL-OMON42693
Completed
N/A
The Efficacy of Pro- and Anticoagulant Therapy in Plasma of Patients with Cirrhosis undergoing Orthotopic Liver Transplantation - EPAC-OLT
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- bleeding
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Orthotopic Liver Transplantation for cirrhosis at the UMCG
- •Age \>18 years
- •Signed informed consent
Exclusion Criteria
- •Acute liver failure
- •Documented history of hereditary thrombophilia
- •Use of vitamin K antagonists
- •Transfusion of blood products (\<7 days)
- •Deep venous thrombosis (\<30 days)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The efficacy of pro- and anticoagulant therapy in plasma from patients with liver cirrhosis .coagulation.hemostasis10064477NL-OMON37417niversitair Medisch Centrum Groningen126
Completed
N/A
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarctionJPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
N/A
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)JPRN-UMIN000021138ihon University school of medicine150
Not Yet Recruiting
Phase 3
Effectiveness and safety of blood thinning agent (Anticoagulation) in patients with dying limb with poor blood supply (Digital Gangrene) and an underlying immune system related disease (Connective Tissue Disease)Health Condition 1: M339- Dermatopolymyositis, unspecifiedHealth Condition 2: M319- Necrotizing vasculopathy, unspecifiedHealth Condition 3: M340- Progressive systemic sclerosisHealth Condition 4: M368- Systemic disorders of connective tissue in other diseases classified elsewhereHealth Condition 5: M359- Systemic involvement of connectivetissue, unspecifiedHealth Condition 6: M321- Systemic lupus erythematosus withorgan or system involvementCTRI/2024/03/063481Department of Clinical Immunology & Rheumatology
Not Yet Recruiting
N/A
The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgerycolorectal cancerJPRN-UMIN000007005Osaka Medical College200